Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Reiterates Lack of Basis for Mexico’s Ban on…
Seed technology companies comply with Mexico’s biosafety regulations, and Mexico should do the same, BIO said today in its response to the panel set up to determine if Mexico’s ban on imports of genetically modified corn violate its commitments…
Biotechnology is a national security Imperative,…
BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry plays as a vital strategic asset: “As a…
WTO 13th Ministerial Conference outcome "positive…
Following the conclusion of the WTO 13th Ministerial Conference in Abu Dhabi, John Murphy -- BIO's Chief Policy Officer -- made the following statement: “We are encouraged that WTO Members did not agree to extend an intellectual property…
All Press Releases
  • Show All
Search
Results
Event Tags
January 29, 2020
WASHINGTON DC., January 30, 2020 – The Biotechnology Innovation Organization (BIO) today released “Measuring Diversity in the Biotech Industry: Building an Inclusive Workforce,” the most comprehensive report on diversity and inclusion in the…
January 15, 2020
Washington, D.C. (January 15, 2020) – BIO President and CEO Jim Greenwood released the following statement today regarding the signing of Phase One of the trade agreement with China: “Trade issues with China have long been a priority for BIO and…
January 10, 2020
Today, the Sustainable Aviation Fuels (SAF) Producers Group together with the Biotechnology Innovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) issued the following statement commending Alaska Airlines’ support for including…
December 19, 2019
The Biotechnology Innovation Organization (BIO) released the following statement in response to House passage of the revised USMCA: “The revised USMCA was a huge missed opportunity to create a positive framework for a dynamic and leading…
December 19, 2019
Washington, D.C. (December 19, 2019) – The Biotechnology Innovation Organization (BIO) today released the following statement in response to EPA finalizing rules on renewable volume obligations for 2020 and SRE reallocation: “Unfortunately, this…
December 18, 2019
Washington, DC (December 18, 2019) – Following the release of the Trump administration’s drug importation proposal, BIO’s President and CEO Jim Greenwood issued the following statement: “Patients deserve access to the medicines they need with…
December 17, 2019
Washington, D.C. (December 17, 2019) – A rider to the FY2020 Agriculture Appropriations Bill will direct the bioengineered AquAdvantage salmon to carry additional labeling to distinguish it from conventionally raised Atlantic salmon. This could be…
December 12, 2019
Former Congressman Jim Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the U.S. Senate confirmed Dr. Stephen Hahn to serve as the next commissioner of the Food and Drug…
December 10, 2019
Exclusion of biologics provisions in revised USMCA sets dangerous precedent for future trade talks, including with China Puts American jobs, intellectual property and leadership in medical innovation at risk WASHINGTON – BIO President and CEO Jim…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.